<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04607486</url>
  </required_header>
  <id_info>
    <org_study_id>S60153</org_study_id>
    <nct_id>NCT04607486</nct_id>
  </id_info>
  <brief_title>Investigation of Changes in Lower Limb Muscles After Cerebrovascular Accident</brief_title>
  <official_title>Reliability Study of a 3D Free-hand Ultrasonography Technique (3DfUS) in Combination With Instrumented Spasticity Assessment (ISA) for the Lower Limb in Chronic First-ever Stroke Patients.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to investigate lower limb muscles after cerebrovascular accident&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to define and differentiate the changes in MMT properties related to&#xD;
      the alterations in muscle tone of the lower limb in first-ever chronic stroke patients by&#xD;
      using a 3D free-hand Ultrasonography (3DfUS) technique in combination with an instrumented&#xD;
      spasticity assessment (IPSA). In these chronic stroke patients, the spontaneous neurological&#xD;
      recovery is stabilized&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 18, 2018</start_date>
  <completion_date type="Anticipated">September 2021</completion_date>
  <primary_completion_date type="Anticipated">August 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>1 Day</target_duration>
  <primary_outcome>
    <measure>Muscle volume</measure>
    <time_frame>1 day</time_frame>
    <description>Estimation of muscle volume by 3D freehand ultrasonography.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Muscle and Tendon Length</measure>
    <time_frame>1 day</time_frame>
    <description>Estimation of muscle volume by 3D freehand ultrasonography</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Echogenicity intensity</measure>
    <time_frame>1 day</time_frame>
    <description>Estimation of echogenicity intensity by 3D freehand ultrasonography on an 8-bit greyscale (256 values).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Work [J] derived from the slow stretch</measure>
    <time_frame>1 day</time_frame>
    <description>Measurement of Work [J] by Instrumented Spasticity Assessment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Muscle activity EMG [uV] derived from the fast stretch</measure>
    <time_frame>1 day</time_frame>
    <description>Measurement of Muscle activity EMG [uV] by Instrumented Spasticity Assessment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Maximal velocity of performance (Vmax [deg/s])</measure>
    <time_frame>1 day</time_frame>
    <description>Measurement of Maximal velocity of performance (Vmax [deg/s]) by Instrumented Spasticity Assessment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Range of motion [deg] for slow stretch</measure>
    <time_frame>1 day</time_frame>
    <description>Measurement of Range of motion [deg] by Instrumented Spasticity Assessment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stiffness [Nm/deg] for slow stretch</measure>
    <time_frame>1 day</time_frame>
    <description>Measurement of Stiffness [Nm/deg] by Instrumented Spasticity Assessment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Joint angle of catch [deg] from the fast stretch</measure>
    <time_frame>1 day</time_frame>
    <description>Measurement of Joint angle of catch [deg] from the fast stretch by Instrumented Spasticity Assessment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Angle of EMG threshold [deg] from the fast stretch</measure>
    <time_frame>1 day</time_frame>
    <description>Measurement of Angle of EMG threshold [deg] by Instrumented Spasticity Assessment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Intensity of catch derived from the fast stretch</measure>
    <time_frame>1 day</time_frame>
    <description>Measurement of Intensity of catch by Instrumented Spasticity Assessment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical assessment of spasticity at fast stretch</measure>
    <time_frame>1 day</time_frame>
    <description>Estimation of spasticity by Modified Assessment Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical assessment of spasticity angle at slow and fast stretch</measure>
    <time_frame>1 day</time_frame>
    <description>Estimation of spasticity by Tardieu Scale</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Quantify the impairment caused by a stroke</measure>
    <time_frame>1 day</time_frame>
    <description>Evaluation of impairment caused by stroke by National Institute Health Stroke Scale</description>
  </other_outcome>
  <other_outcome>
    <measure>Assessments of functional independence in daily life in stroke patients and healthy subjects</measure>
    <time_frame>1 day</time_frame>
    <description>Evaluation of functional independence in daily life is assessed by the Barthel Index</description>
  </other_outcome>
  <other_outcome>
    <measure>Assessments of functional status after stroke</measure>
    <time_frame>1 day</time_frame>
    <description>Evaluation of functional status after stroke is assessed by the Functional Independence Measure</description>
  </other_outcome>
  <other_outcome>
    <measure>Assessesment of mobility in stroke patients</measure>
    <time_frame>1 day</time_frame>
    <description>Evaluation of mobility after stroke is assessed by the Rivermead Mobility Index</description>
  </other_outcome>
  <other_outcome>
    <measure>Assessment of transfer skills in stroke patients and healthy subjects</measure>
    <time_frame>1 day</time_frame>
    <description>Measurement of functional lower extremity strength and/or identify movement strategies in stroke patients and healthy subjects by The Five Times Sit to Stand Test</description>
  </other_outcome>
  <other_outcome>
    <measure>Assessment of the motor impairment in lower limbs of stroke patients</measure>
    <time_frame>1 day</time_frame>
    <description>Measurement of lower limb strength in stroke patients by the Motricity Index</description>
  </other_outcome>
  <other_outcome>
    <measure>Assessments of gait speed analysis in stroke patients and healthy subjects.</measure>
    <time_frame>Measurement of gait speed in stroke patients and healthy subjects by 5-Meter Walk Test at comfortable or self-selected gait speed.</time_frame>
    <description>1 day</description>
  </other_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Cerebrovascular Accident</condition>
  <arm_group>
    <arm_group_label>CVA and spasticity</arm_group_label>
    <description>Adults with first-ever chronic CVA and leg spasticity</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CVA without spasticity</arm_group_label>
    <description>Control group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>healthy subjects</arm_group_label>
    <description>Control group</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>3DfUS and IPSA of leg muscles</intervention_name>
    <description>3DfUS technique enhances a conventional 2D US device into a platform capable of reconstructing 3D anatomical data sets.&#xD;
IPSA for quantification of hyper-resistance and its underlying components. The sensors in the IPSa include gyroscopes and accelerometers to measure joint angle and angular velocity, EMG to measure muscle activity, and a 3 degrees-of freedom force sensor to measure torque applied on the joint.&#xD;
clinical functional capacity = clinical evaluation of degree of independence, mobility and gait</description>
    <arm_group_label>CVA and spasticity</arm_group_label>
    <arm_group_label>CVA without spasticity</arm_group_label>
    <arm_group_label>healthy subjects</arm_group_label>
    <other_name>clinical functional capacity</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adults with first ever chronic stroke:&#xD;
&#xD;
        = First ever stroke subjects with established spasticity and without spasticity will be&#xD;
        recruited on the stroke rehabilitation unit and outpatient rehabilitation clinic,&#xD;
        University Hospital of Leuven.&#xD;
&#xD;
        Healthy control subjects&#xD;
&#xD;
        = Healthy age-and gender matched subjects will be recruited among healthy university staff&#xD;
        of the University Hospital of Leuven, their family and friends.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Definition of case population :&#xD;
&#xD;
             o first ever stroke with spasticity of the lower limb.&#xD;
&#xD;
          -  Definition of control :&#xD;
&#xD;
               -  first ever stroke without spasticity of the lower limb&#xD;
&#xD;
               -  healthy aged-matched subjects&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Musculoskeletal or neurological problems affecting the lower limb&#xD;
&#xD;
          -  Presence of other neurological pathology that could lead to spasticity, ataxia,&#xD;
             dystonia&#xD;
&#xD;
          -  Cognitive problems that impede measurements&#xD;
&#xD;
          -  Severe co-morbidities&#xD;
&#xD;
          -  Peripheral spastic medication&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fabienne Schillebeeckx, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UZ Leuven</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Fabienne Schillebeeckx, MD</last_name>
    <phone>0032 16 33 87 14</phone>
    <email>fabienne.schillebeeckx@uzleuven.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>UZ Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fabienne Schillebeeckx, MD</last_name>
      <email>fabienne.schillebeeckx@uzleuven.be</email>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>August 6, 2020</study_first_submitted>
  <study_first_submitted_qc>October 22, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 29, 2020</study_first_posted>
  <last_update_submitted>October 22, 2020</last_update_submitted>
  <last_update_submitted_qc>October 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

